Sajith Wickramasekara started biotech R&D software company Benchling in his MIT dorm room. Now it's worth $850 million. Sajith Wickramasekara started working on an idea for a cloud-based Crispr design ...
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /CNW/ -- Benchling today unveiled major new capabilities at ...
Antibody R&D teams can configure any format in minutes and register up to 1,000 antibodies in a single run "Most R&D systems can't represent the antibody formats teams are actually working with," said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results